Parent’s and Children Corner
Welcome and thank you for visiting the ITCC website.
ITCC is an European group working to improve access to new drugs for children.
The new EU paediatric regulation should be good news for everyone; children will now have earlier access to many more potential treatments. The new law will encourage the design of safe and effective new treatments for children with cancer to improve the cure rate and quality of life.
One of the major objectives of ITCC is to improve access to information on and the ethical aspects of clinical research in children with life-threatening diseases. Parents, patients and their representatives are involved throughout the project, and the International Confederation of Children Cancer Parent Organisations (ICCCPO) is a full-partner of the ITCC Consortium.
This area of the website is dedicated to providing information to patients and parents and aims to answer frequently asked questions:
- What is a Clinical Trial ?
- Who sponsors clinical trials?
- What is Randomisation?
- What is a blind trial?
- What is behind the phrase «Innovative therapies”?
- Why clinical trials are necessary to support innovation?
- Why is a new regulation necessary? What will it change ?
- Is it ethical to conduct phase I trials in children with cancer?
- Questions Regarding Clinical Trials ?
